Cargando…

Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon

BACKGROUND/PURPOSE: Lack of robust, feasible, and quantitative outcomes impedes Raynaud phenomenon (RP) clinical trials in systemic sclerosis (SSc) patients. Hyperspectral imaging (HSI) non-invasively measures oxygenated and deoxygenated hemoglobin (oxyHb and deoxyHb) concentrations and oxygen satur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teaw, Shannon, Gupta, Akash, Williams, Alyssa, Wilson, F. Perry, Sumpio, Brandon J., Sumpio, Bauer E., Hinchcliff, Monique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854186/ https://www.ncbi.nlm.nih.gov/pubmed/36670487 http://dx.doi.org/10.1186/s13075-023-02990-3

Ejemplares similares

Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis
por: Amor-Dorado, Juan Carlos, et al.
Publicado: (2023)

Raynaud’s Phenomenon with Focus on Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2022)

Raynaud’s phenomenon
por: Solomons, HD
Publicado: (2011)

Raynaud's Phenomenon
por: Shah, Jehan, et al.
Publicado: (2013)

Computer vision applied to dual-energy computed tomography images for precise calcinosis cutis quantification in patients with systemic sclerosis
por: Chandrasekaran, Anita C., et al.
Publicado: (2021)

Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon
por: Kundu, Devi, et al.
Publicado: (2014)

Systemic lupus erythematosus and Raynaud's phenomenon
por: Heimovski, Flavia Emilie, et al.
Publicado: (2015)

Contemporary Evaluation and Management of the Diabetic Foot
por: Sumpio, Bauer E.
Publicado: (2012)

Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
por: Arefiev, Kait, et al.
Publicado: (2011)

Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments
por: Korsten, Peter, et al.
Publicado: (2019)

Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review
por: Cai, Ruyi, et al.
Publicado: (2022)

Advances in the treatment of Raynaud’s phenomenon
por: Levien, Terri L
Publicado: (2010)

Raynaud's phenomenon in pediatric age
por: Tavares, M, et al.
Publicado: (2011)

Raynaud's Phenomenon: Beware of Cancers!
por: Aqodad, Zahida, et al.
Publicado: (2021)

Solvent-Induced Raynaud’s Phenomenon
por: Rodrigues, Helena, et al.
Publicado: (2023)

Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud’s phenomenon
por: Park, Jin-Su, et al.
Publicado: (2015)

Recent achievements in the management of Raynaud’s phenomenon
por: Baumhäkel, Magnus, et al.
Publicado: (2010)

Glomus Tumor Presenting as Raynaud's Phenomenon
por: Abdelrahman, M. H., et al.
Publicado: (2012)

Monostotic fibrous dysplasia with Raynaud's phenomenon
por: Kumar, K. V. S. Hari, et al.
Publicado: (2015)

Pacinian hyperplasia presenting with Raynaud’s phenomenon
por: Pickrell, Brent B., et al.
Publicado: (2019)

Prevalence of Raynaud’s Phenomenon in Saudi Arabia
por: Mustafa, Mohammad, et al.
Publicado: (2022)

Lower limb ulcer and Raynaud's phenomenon
por: Chérif, Mohammad Yassine, et al.
Publicado: (2022)

Raynaud’s Phenomenon: A Brush Up!
por: Swarnkar, Bhavya, et al.
Publicado: (2023)

A violist with asymmetrical Raynaud’s phenomenon
por: Silva, Beatriz C, et al.
Publicado: (2023)

Raynaud’s phenomenon in childhood-onset systemic lupus erythematous
por: Jiang, Qi, et al.
Publicado: (2022)

Artifactual Hypoglycaemia in Systemic Sclerosis and Raynaud's Phenomenon: A Clinical Case Report and Short Review
por: Bishay, RH, et al.
Publicado: (2016)

Association between systemic sclerosis, palmar fasciitis with polyarthritis, Raynaud’s phenomenon and erythromelalgia with underlying malignancy
por: Nowak, Katarzyna, et al.
Publicado: (2022)

Characteristic Features of Infrared Thermographic Imaging in Primary Raynaud’s Phenomenon
por: Lindberg, Lotte, et al.
Publicado: (2021)

Charcot foot and ankle with osteomyelitis
por: Donegan, Ryan, et al.
Publicado: (2013)

Digital Thermography of the Fingers and Toes in Raynaud's Phenomenon
por: Lim, Mie Jin, et al.
Publicado: (2014)

Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
por: Güneş, Serkan, et al.
Publicado: (2018)

Innovations in the Assessment of Primary and Secondary Raynaud’s Phenomenon
por: Ruaro, Barbara, et al.
Publicado: (2019)

Raynaud’s Phenomenon: Reviewing the Pathophysiology and Management Strategies
por: Nawaz, Iqra, et al.
Publicado: (2022)

The frequency of Raynaud’s phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database
por: Frech, Tracy M., et al.
Publicado: (2021)

The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort
por: Silva, Cherumi, et al.
Publicado: (2022)

Efficacy of botulinum toxin type A injection for Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis
por: Jokar, Mohammad Hassan, et al.
Publicado: (2022)

Association of Raynaud’s phenomenon with a polymorphism in the NOS1 gene
por: Munir, Sabrina, et al.
Publicado: (2018)

Heterogeneity in the guidelines for the management of diabetic foot disease in the Caribbean
por: Sumpio, Bauer E., et al.
Publicado: (2022)

Progressive Systemic Sclerosis With Negative Antinuclear Antibodies and Absence of Raynaud’s Phenomenon: A Case Report and Literature Review
por: Falls, Anna C, et al.
Publicado: (2023)

Local hyperhemia to heating is impaired in secondary Raynaud's phenomenon
por: Boignard, Aude, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_kf2b6sm7d5o4hfnk4k6bg1pke6